USPTO Examiner MARLEN TAMMIE K - Art Unit 3796

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19098512SYSTEM AND METHOD FOR INTRAOPERATIVE GUIDANCEApril 2025December 2025Allow820YesNo
19098521SYSTEM AND METHOD FOR NERVE HEALTH ASSESSMENTApril 2025August 2025Allow510YesNo
18987764DEVICE TO ASSIST THE PERFORMANCE OF A HEARTDecember 2024March 2025Allow310YesNo
18909088DEVICE TO ASSIST THE PERFORMANCE OF A HEARTOctober 2024February 2025Allow420NoNo
18906911DEVICE TO ASSIST THE PERFORMANCE OF A HEARTOctober 2024February 2025Allow420NoNo
18799984SYSTEM AND METHOD FOR ASSESSING NERVE HEALTH DURING A SPINAL DECOMPRESSION PROCEDUREAugust 2024December 2024Allow410YesNo
18795656DEVICE TO ASSIST THE PERFORMANCE OF A HEARTAugust 2024October 2024Allow210NoNo
18759184MEDICAL ASSESSMENT DEVICE AND SYSTEM FOR DIAGNOSES OF NEUROLOGICAL AND OTHER CONDITIONSJune 2024September 2025Allow1400NoNo
18740119DEVICE TO ASSIST THE PERFORMANCE OF A HEARTJune 2024September 2024Allow300YesNo
18735157CARDIAC ELECTRICAL SIGNAL GROSS MORPHOLOGY-BASED NOISE DETECTION FOR REJECTION OF VENTRICULAR TACHYARRHYTHMIA DETECTIONJune 2024November 2025Allow1700YesNo
18711830LEAD DEVICE FOR IMPROVED PUNCTURING FOR CARDIAC STIMULATIONMay 2024June 2025Allow1320YesNo
18666363APPARATUS AND METHOD FOR LEFT VENTRICULAR EJECTION FRACTION PREDICTIONMay 2024July 2025Allow1430YesNo
18594907IMPLANTABLE MEDICAL DEVICEMarch 2024August 2024Allow610NoNo
18581210METHOD AND SYSTEM FOR IMPLANTING A SEPTAL WALL ELECTRODEFebruary 2024February 2025Allow1110NoNo
18429130Methods for automatic cough detection and uses thereofJanuary 2024May 2024Allow310NoNo
18397916MEDICAL ASSESSMENT DEVICE AND SYSTEM FOR DIAGNOSES OF NEUROLOGICAL AND OTHER CONDITIONSDecember 2023June 2024Allow620YesNo
18393000Therapy Implemented Using Different Sub-Perception Neuromodulation TypesDecember 2023January 2026Allow2520YesNo
18507472BRAIN STIMULATION SYSTEM INCLUDING DIAGNOSTIC TOOLNovember 2023December 2025Abandon2520NoNo
18499327METHOD AND SYSTEM WITH CURRENT REGULATOR BIASED BY FLOATING POWER SUPPLYNovember 2023October 2025Allow2300YesNo
18497198WEARABLE NEUROMODULATOR DEVICESOctober 2023May 2025Allow1801NoNo
18381219DUAL LUMEN SHEATH FOR ARTERIAL ACCESSOctober 2023November 2024Allow1310NoNo
18234269EPICARDIAL LEAD DESIGNAugust 2023November 2025Abandon2701NoNo
18363166DEVICE TO ASSIST THE PERFORMANCE OF A HEARTAugust 2023July 2024Allow1200YesNo
18223369OPTIMIZATION TOOL FOR AUDITORY DEVICESJuly 2023September 2024Allow1420YesNo
18216151TUMOR TREATING FIELD TRANSDUCERS WITH PROTECTIVE BORDER, AND APPARATUSES AND METHODS FOR ACTIVE DETECTION OF IMPROPER TRANSDUCER CONFIGURATIONJune 2023March 2026Allow3220NoNo
18333905SYSTEM AND METHODS OF DECREASING THE DIRECTIONAL SENSITIVITY OF AXIALLY ALIGNED RECHARGEABLE IMPLANTJune 2023January 2024Allow700NoNo
18317804PHOTOBIOMODULATION THERAPY SYSTEMS AND METHODSMay 2023April 2024Abandon1110NoNo
18036753APPARATUS, METHOD AND COMPUTER PROGRAM FOR TREATING BENIGN PAROXYSMAL POSITIONAL VERTIGOMay 2023January 2026Abandon3210NoNo
18309229MULTI-ELECTRODE STIMULATION THERAPY WITH REDUCED ENERGYApril 2023July 2024Allow1510NoNo
18307389REMOTE HEALTH MONITORING SYSTEMApril 2023March 2024Allow1110YesNo
18135345METHOD FOR ADJUSTING A SYSTEM FOR STIMULATING A HYPOGLOSSAL NERVEApril 2023July 2025Allow2740YesNo
18132657ELECTRONIC DEVICE AND METHOD OF ESTIMATING HUMAN BODY MICROCLIMATE TEMPERATURE USING THE SAMEApril 2023August 2025Allow2810NoNo
18187162COMBINATION IMPLANT SYSTEM WITH REMOVABLE EARPLUG SENSOR AND IMPLANTED BATTERYMarch 2023July 2025Allow2810NoNo
18181916INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING METHOD, AND STORAGE MEDIUMMarch 2023November 2025Allow3210YesNo
18112929SYSTEM FOR VARIABLY CONFIGURABLE, ADAPTABLE ELECTRODE ARRAYS AND EFFECTUATING SOFTWAREFebruary 2023September 2024Allow1900NoNo
18105062Electrical Energy Power Source Connected To An Active Medical Device Through A Flex CircuitFebruary 2023September 2025Allow3111NoNo
18163173PRENATAL MONITORING SYSTEMFebruary 2023March 2026Allow3720YesNo
18102106HEART PUMP WITH PASSIVE PURGE SYSTEMJanuary 2023October 2025Allow3311NoNo
18093638WEARABLE ASSEMBLIES FOR TISSUE STIMULATIONJanuary 2023February 2025Abandon2610YesNo
17803844ENDOTRACER AND ENDOPACER SYSTEMS AND PROCESSES INCLUDING USING AT LEAST TWO ELECTRODESDecember 2022October 2025Abandon3410YesNo
18060704PHOTOBIOMODULATION THERAPY SYSTEMS AND METHODSDecember 2022May 2024Abandon1820YesNo
17984199METHODS AND DEVICES FOR TREATING PELVIC CONDITIONSNovember 2022January 2024Allow1530YesNo
17900585SENSOR DEVICEAugust 2022December 2025Abandon4020NoNo
17821964CARDIAC AND TEMPERATURE MONITORAugust 2022September 2025Allow3720YesNo
17893710DEVICE AND METHOD FOR NEUROMODULATIONAugust 2022September 2025Abandon3720NoNo
17889115ADJUSTABLE ILLUMINATOR FOR PHOTODYNAMIC THERAPY AND DIAGNOSISAugust 2022October 2024Allow2600YesNo
17866445WEARABLE DEVICES FOR PROVIDING A QUALITATIVE AND ACTIONABLE DESCRIPTOR OF A USER'S PHYSIOLOGICAL STATE, AND METHODS OF USE THEREOFJuly 2022March 2025Allow3210YesNo
17809965Cardiac Stimulation Apparatus and Method for the Control of HypertensionJune 2022February 2024Allow2010YesNo
17854078Penetration of Cerebral Spinal Fluid into the Brain Parenchyma Using Temporally Patterned NeuromodulationJune 2022May 2024Allow2210NoNo
17853675SYSTEMS, METHODS AND DEVICES FOR A SKULL/BRAIN INTERFACEJune 2022November 2024Abandon2910NoNo
17848776CONNECTOR FOR IMPLANTABLE MEDICAL DEVICEJune 2022December 2025Allow4121YesNo
17837451ATRIAL SYNCHRONIZED VENTRICULAR PACING SYSTEMJune 2022July 2025Allow3730YesNo
17825226SYSTEM AND METHOD FOR AUTOMATICALLY MONITORING PHYSIOLOGICAL PARAMETERS OF A SUBJECTMay 2022September 2025Abandon3930NoYes
17744446WEARABLE BLOOD PRESSURE BIOSENSORS, SYSTEMS AND METHODS FOR SHORT-TERM BLOOD PRESSURE PREDICTIONMay 2022April 2025Abandon3610NoNo
17742551NONCONTACT VITAL SIGN SENSING DEVICEMay 2022November 2024Allow3010NoNo
17732461CARDIAC ELECTRICAL SIGNAL GROSS MORPHOLOGY-BASED NOISE DETECTION FOR REJECTION OF VENTRICULAR TACHYARRHYTHMIA DETECTIONApril 2022February 2024Allow2110YesNo
17657197INTEGRATED RESUSCITATIONMarch 2022March 2025Abandon3530YesNo
17696825SMART INFANT MONITORING SYSTEM AND METHODMarch 2022August 2025Allow4121YesNo
17634011SYSTEMS FOR NOISE-SENSITIVE PATIENT-SPECIFIC ADJUSTMENTS OF NEUROMODULATION PARAMETERSFebruary 2022March 2025Allow3811YesNo
17622064METHODS AND DEVICES FOR TREATING EXTERNAL FIXATION SITESDecember 2021April 2025Abandon3930NoNo
17537808PHOTOSENSITIVE PIXEL STRUCTURE WITH INCREASED LIGHT ABSORPTION AND PHOTOSENSITIVE IMPLANTNovember 2021September 2024Allow3430YesNo
17526156ELECTROCARDIOGRAM MEASUREMENT DEVICE FOR VEHICLE, SYSTEM INCLUDING THE SAME, AND METHOD THEREFORNovember 2021December 2023Allow2520NoNo
17609755AN IMPLANTABLE ELECTRICAL STIMULATION DEVICE WITH A FLEXIBLE ELECTRODENovember 2021August 2024Allow3320NoYes
17520092ADAPTIVE DEEP BRAIN STIMULATION OF THE SUPEROLATERAL MEDIAL FOREBRAIN BUNDLENovember 2021August 2024Allow3320NoNo
17514169CURRENT STIMULATION DEVICE AND OSTEOBLAST DIFFERENTIATION TREATMENT SYSTEM THROUGH CURRENT STIMULATIONOctober 2021February 2024Abandon2810NoNo
17450271SLEEP APNEA THERAPYOctober 2021February 2024Abandon2820YesNo
17478455ELECTRICAL DISCHARGE IRRIGATOR APPARATUS AND METHODSeptember 2021April 2024Allow3130NoYes
17460535AUTOMATED EXTERNAL DEFIBRILLATOR SYSTEMS AND METHODS OF USEAugust 2021August 2024Abandon3530NoNo
17395347SYSTEM AND METHOD FOR REDUCING FALSE ALARMS ASSOCIATED WITH VITAL-SIGNS MONITORINGAugust 2021October 2025Allow5031YesNo
17377675IMPLANTABLE MEDICAL DEVICEJuly 2021December 2023Allow2920YesNo
17378334SMART PLATE SENSORSJuly 2021July 2025Allow4831NoNo
17368059COMPOSITE HEADER SEALSJuly 2021November 2025Abandon5260NoNo
17340723URINARY INCONTINENCE TREATMENT DEVICE AND METHOD FOR USING THE SAMEJune 2021October 2024Abandon4040NoNo
17295005Systems and Methods for Controlling Wirelessly Powered Leadless PacemakersMay 2021September 2023Allow2810NoNo
17319937SYSTEM AND METHOD FOR SKIN REJUVENATION USING IMPEDANCE MONITORINGMay 2021November 2025Allow5450YesNo
17242688METHOD OF MANAGING DISEASE, AND APPARATUSES OPERATING THE SAMEApril 2021January 2025Abandon4510NoNo
17242254STETHOSCOPE AND ELECTRONIC AUSCULTATION APPARATUSApril 2021February 2025Abandon4620NoNo
17241279EPILEPTIC EVENT DETECTION BASED ON CORRELATION OF BODY SIGNALSApril 2021July 2024Allow3920NoNo
17239523SYSTEMS, DEVICES AND METHODS FOR PHYSIOLOGICAL MONITORING OF PATIENTSApril 2021August 2023Allow2820YesNo
17285347APPARATUS AND METHOD FOR TRANSORAL MINIMALLY INVASIVE TREATMENT OF GASTROINTESTINAL DISEASESApril 2021January 2024Allow3321NoNo
17224416RESCUE SCENE VIDEO TRANSMISSIONApril 2021February 2025Allow4720YesNo
17301037DEVICES, SYSTEMS, AND METHODS FOR STIMULATION THERAPYMarch 2021March 2024Abandon3630YesNo
17190594IMPLANTABLE APPARATUSMarch 2021July 2024Allow4031YesNo
17186946BRAIN STIMULATION SYSTEM INCLUDING DIAGNOSTIC TOOLFebruary 2021February 2024Abandon3520NoYes
17179974DEVICES AND METHODS FOR MEASURING JUGULAR VENOUS PRESSUREFebruary 2021May 2024Allow3920YesNo
17269777METHOD AND APPARATUS FOR DERIVING BIOMETRIC INFORMATION USING MULTIPLE-AXIS SEISMOCARDIOGRAPHYFebruary 2021June 2025Allow5230NoNo
17178886SYSTEMS AND METHODS FOR USING A WEARABLE HEALTH MONITORFebruary 2021January 2024Allow3510NoNo
17175063IMPLANTABLE MEDICAL DEVICE INCLUDING ELECTRODES FORMED THEREINFebruary 2021March 2024Allow3721NoYes
17162610IN-VIVO IMPLANTABLE MEDICAL DEVICEJanuary 2021October 2024Allow4520YesNo
17261716IMPLANTABLE MEDICAL DEVICE SHORT-RANGE RADIO SYNCHRONIZATIONJanuary 2021September 2023Allow3211NoNo
17261394BIOSENSOR DEVICEJanuary 2021January 2024Allow3510NoNo
17261146SYSTEMS AND METHODS FOR MONITORING PHYSIOLOGICAL PARAMETERS DURING DIATHERMYJanuary 2021April 2024Allow3910NoNo
17145711METHODS AND APPARATUS FOR PORTABLE UNIVERSAL MONITORING DEVICEJanuary 2021January 2025Abandon4820NoNo
17125018CONNECTOR FOR USE IN OVERMOLDED HEADER OF IMPLANTABLE PULSE GENERATORDecember 2020October 2023Allow3430NoNo
17120533AUTOMATED EXTERNAL DEFIBRILLATOR SYSTEMS AND METHODS OF USEDecember 2020July 2024Abandon4340NoNo
17110469FRACTIONAL TREATMENT OF URINARY INCONTINENCEDecember 2020November 2023Allow3620NoNo
17107457PURGE-FREE MINIATURE ROTARY PUMPNovember 2020May 2024Allow4240YesNo
17097571RISK MANAGEMENT DEVICE, RISK MANAGEMENT METHOD, AND NON-TEMPORARY RECORDING MEDIUM IN WHICH RISK MANAGEMENT PROGRAM IS STOREDNovember 2020January 2024Allow3910YesNo
17089333SYSTEM OF EPICARDIAL SENSING AND PACING FOR SYNCHRONIZING A HEART ASSIST DEVICENovember 2020March 2025Abandon5240YesNo
17052832DEVICE AND METHOD FOR ASSESSING, PREDICTING AND OPERATING USERS HEALTH IN REAL TIMENovember 2020April 2024Abandon4110NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner MARLEN, TAMMIE K.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
9
Examiner Affirmed
7
(77.8%)
Examiner Reversed
2
(22.2%)
Reversal Percentile
35.8%
Lower than average

What This Means

With a 22.2% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
22
Allowed After Appeal Filing
7
(31.8%)
Not Allowed After Appeal Filing
15
(68.2%)
Filing Benefit Percentile
49.0%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 31.8% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner MARLEN, TAMMIE K - Prosecution Strategy Guide

Executive Summary

Examiner MARLEN, TAMMIE K works in Art Unit 3796 and has examined 88 patent applications in our dataset. With an allowance rate of 83.0%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 39 months.

Allowance Patterns

Examiner MARLEN, TAMMIE K's allowance rate of 83.0% places them in the 56% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by MARLEN, TAMMIE K receive 2.72 office actions before reaching final disposition. This places the examiner in the 80% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by MARLEN, TAMMIE K is 39 months. This places the examiner in the 28% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +11.5% benefit to allowance rate for applications examined by MARLEN, TAMMIE K. This interview benefit is in the 46% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 24.2% of applications are subsequently allowed. This success rate is in the 35% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 33.3% of cases where such amendments are filed. This entry rate is in the 50% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 75.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 61% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 59.1% of appeals filed. This is in the 34% percentile among all examiners. Of these withdrawals, 30.8% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 52.6% are granted (fully or in part). This grant rate is in the 53% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 8.0% of allowed cases (in the 91% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 51% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.